Evaluation of a new serum testing method for detection of prostate cancer

Journal of Urology

Volumn 168, Issue 1, 2002, Pages 93-99

  Seabury, Charles A ^a,b   Calenoff, Emanuel ^a,b   Ditlow, Charles ^a,b   Bux, Sajit ^a,b   Clarke, Harry ^a,b   Issa, Muta ^a,b   Marshall, Fray ^a,b   Petros, John ^a,b  

^a EMORY UNIVERSITY   (United States)

^b NONE

Author keywords

Glycosylation; Membrane proteins; Prostatic neoplasms

Indexed keywords

CELL SURFACE PROTEIN; PEPTIDE FRAGMENT; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ANTIBODY PRODUCTION; ANTIBODY TITER; ARTICLE; CANCER SCREENING; CLINICAL ARTICLE; CONTROLLED STUDY; DEGLYCOSYLATION; HUMAN; MALE; PRIORITY JOURNAL; PROSTATE CANCER; SENSITIVITY AND SPECIFICITY; SERUM;

EID: 0036285391     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(05)64838-0     Document Type: Article

References (29)

1. Prostate cancer. When to offer screening in the primary care setting
2. The inability of prostate specific antigen index to enhance the predictive value of prostate specific antigen in the diagnosis of prostatic carcinoma
3. Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: A prospective multicenter clinical trial
4. Ratio of free-to-total prostate specific antigen in serum cannot distinguish patients with prostate cancer from those with chronic inflammation of the prostate
5. Diagnostic value of prostate-specific antigen-related parameters in discriminating prostate cancer
6. Immunity to oncogenic proteins
7. Aberrant glycosylation in tumors and tumor-associated carbohydrate antigens
8. Co-ordinated changes in expression of cell adhesion molecules in prostate cancer
9. Expression of CD44 isoforms in human prostate tumor cell lines
10. Relative expression of type IV collagenase, E-cadherin, and vascular endothelial growth factor/vascular permeability factor in prostatectomy specimens distinguishes organ-confined from pathologically advanced prostate cancer
11. N-cadherin expression in human prostate carcinoma cell lines. An epithelial-mesenchymal transformation mediating adhesion with stromal cells
12. Analysis and sorting of prostate cancer cell types by flow cytometry
13. Tumor-suppressive activity of CD66a in prostate cancer
14. A tyrosine kinase profile of prostate carcinoma
15. Alternative splicing of fibroblast growth factor receptors in human prostate cancer
16. Co-expression of hepatocyte growth factor and its receptor in human prostate cancer
17. Immunohistochemistry analysis of platelet-derived growth factor A and B chains and platelet-derived growth factor alpha and beta receptor in benign prostatic hyperplasias and Gleason-graded human prostate adenocarcinomas
18. Expression of cellular adhesion molecules on human prostate tumor cell lines
19. Prostatic carcinoma cell migration via alpha(v)beta 3 integrin is modulated by a focal adhesion kinase pathway
20. The alpha 6 beta 1 and alpha 6 beta 4 integrins in human prostate cancer progression
21. Transforming growth factor beta as a clinical biomarker for prostate cancer
22. Type-1 insulin-like growth factor receptor reexpression in the malignant phenotype of SV40-T-immortalized human prostate epithelial cells enhances apoptosis
23. MUC-1 epithelial tumor, mucin-based immunity and cancer vaccines
24. Analysis of glycoconjugate patterns of normal and hormone-induced dysplastic Noble rat prostates, and an androgen-independent Noble rat prostate tumor, by lectin histiochemistry and protein blotting
25. A lectin histochemistry comparative study in human normal prostate, benign prostatic hyperplasia, and prostatic carcinoma
26. Natural antibodies to avidin in human serum
27. Antibodies against biotinylated proteins are present in normal human serum
28. Differential expression of cell surface molecules in prostate cancer cells